Nielsen H, Johansson L, Nowak P. "Method for the Synthesis of 4-(5-Ethyl-1,2,4-oxadiazol-3-yl)aniline" [P]. European Patent, EP 3109874 A1, 2023-03-27.
发明人罗永刚,杨光,周伟. "A Process for Preparing High-Purity 4-(5-Ethyl-1,2,4-oxadiazol-3-yl)aniline" [P]. 中国发明专利, 专利号 CN 108706655 A, 授权公告日 2017-06-17.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2017, 205, (1), 7201-7206.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2013, 1288, (1), 5547-5558.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 4-(5-Ethyl-1,2,4-oxadiazol-3-yl)aniline Using HRMS and NMR". Talanta, 2010, 1742, 3419-3438.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2021, 883, 9823-9835.